Cell Banking Outsourcing Market Growth: Market Challenges and Future Prospects
Cell
Banking Outsourcing Market size in 2022 was USD 9969.50 million, and from
2022 to 2030 it is predicted to grow at a CAGR of 16.2% and is expected to
reach USD 33137.7 Million by 2030.
The Cell Banking Outsourcing Market Report provides a
comprehensive analysis of the global Cell Banking Outsourcing market,
highlighting key trends, growth drivers, challenges, and opportunities. The
report aims to assist industry stakeholders in making informed decisions and
formulating effective strategies.
The Cell Banking Outsourcing Market is a rapidly growing
sector in the biopharmaceutical industry. As companies increasingly focus on
developing advanced cell therapies and personalized medicine, the need for
reliable and efficient cell banking services has become paramount.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2836
Cell banking involves the preservation and storage of cells,
tissues, or cell lines for future use in research, drug development, or
clinical applications. It plays a crucial role in ensuring the quality, safety,
and consistency of cell-based products throughout their lifecycle. However,
establishing and maintaining an in-house cell banking facility can be expensive
and time-consuming for many organizations.
This is where outsourcing comes into play. Cell banking
outsourcing offers several advantages to biopharmaceutical companies. Firstly,
it allows them to leverage the expertise of specialized service providers who
have extensive experience in handling various types of cells and complying with
regulatory requirements.
KEY MARKET SEGMENTS
By Type:
·
Master Cell Banking
·
Working Cell Banking
·
Viral Cell Banking
By Cell Type:
·
Stem Cell
o Cord Cell Banking
o Embryonic Stem Cell Banking
o Adult Stem Cell Banking
o Dental Stem Cell Banking
o IPS Stem Cell Banking
·
Non-Stem Cell
By Phase:
·
Bank Storage
o Master Cell Bank Storage
o Working Cell Bank Storage
o Cell Storage Stability
Testing
·
Bank Characterization & Testing
o Safety
Testing
§ Viral Cell
Banks
§ Microbial
Cell Banks
o Gene
Expression Testing
o Karyology
Testing
o Gene
Sequencing Testing
·
Bank Preparation
o Master Cell
Bank Preparation
o Working
Cell Bank Preparation
Major Players Listed in the Report
are as Follows:
Charles River Laboratories International, Inc. and Lonza
Group Ltd., SGS SA, Goodwin Biotechnology Inc., Eurofins Scientific SE,
ViruSure GmbH, WuXi AppTec, Inc., BioReliance Corporation, a unit of Merck
KGaA, Toxikon Corporation, and Texcell, Inc., and other players listed in the
final report.
Other Report
About US:
SNS Insider has been a leader in data and analytics globally
with its authentic consumer and market insights. The trust of our clients and business
partners has always been at the center of who we are as a company. We are a
business that leads the industry in innovation, and to support the success of
our clients, our highly skilled engineers, consultants, and data scientists
have consistently pushed the limits of the industry with innovative methodology
and measuring technologies.
We assist our clients to anticipate industrial, economic,
and consumer trends to drive disruptive change by fusing global experience with
local information from experts throughout the world. We bring context to
strategic and tactical data by bridging approaches based on data science and
field research, assisting you in addressing your most pressing problems and
spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Comments
Post a Comment